Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain

BACKGROUND: The current healthcare climate demands pharmacoeconomic evaluations for different treatment strategies incorporating drug acquisition costs, costs incurred for hospitalisation, drug administration and preparation, diagnostic and laboratory testing and drug-related adverse events (AEs). H...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostermann, Helmut, Solano, Carlos, Jarque, Isidro, Garcia-Vidal, Carolina, Gao, Xin, Barrueta, Jon Andoni, De Salas-Cansado, Marina, Stephens, Jennifer, Xue, Mei, Weber, Bertram, Charbonneau, Claudie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183350/
https://www.ncbi.nlm.nih.gov/pubmed/25253630
http://dx.doi.org/10.1186/2050-6511-15-52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183350/
https://www.ncbi.nlm.nih.gov/pubmed/25253630
http://dx.doi.org/10.1186/2050-6511-15-52

Ejemplares similares